As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.
12 Analysts have issued a MediWound Ltd. forecast:
12 Analysts have issued a MediWound Ltd. forecast:
Jun '25 |
+/-
%
|
||
Revenue | 20 20 |
1%
1%
|
|
Gross Profit | 3.66 3.66 |
37%
37%
|
|
EBITDA | -21 -21 |
50%
50%
|
EBIT (Operating Income) EBIT | -22 -22 |
46%
46%
|
Net Profit | -28 -28 |
40%
40%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
MediWound Ltd. is a biopharmaceutical company engaging in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in 2001 and is headquartered in Yavne, Israel.
Head office | Israel |
CEO | Ofer Gonen |
Employees | 111 |
Founded | 2000 |
Website | www.mediwound.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.